193 related articles for article (PubMed ID: 24791588)
1. 2,4-Dihydroxychalcone derivatives as novel potent cell division cycle 25B phosphatase inhibitors and protein tyrosine phosphatase 1B inhibitors.
Xie C; Sun Y; Pan CY; Tang LM; Guan LP
Pharmazie; 2014 Apr; 69(4):257-62. PubMed ID: 24791588
[TBL] [Abstract][Full Text] [Related]
2. Chalcones derivatives as potent Cell division cycle 25B phosphatase inhibitors.
Zhang J; Ji FJ; Gu Y; Zhang XY; Qiao SX
Pharmacol Rep; 2014 Jun; 66(3):515-9. PubMed ID: 24905533
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604
[TBL] [Abstract][Full Text] [Related]
7. Facile fabrication of promising protein tyrosine phosphatase (PTP) inhibitor entities based on 'clicked' serine/threonine-monosaccharide hybrids.
He XP; Deng Q; Gao LX; Li C; Zhang W; Zhou YB; Tang Y; Shi XX; Xie J; Li J; Chen GR; Chen K
Bioorg Med Chem; 2011 Jul; 19(13):3892-900. PubMed ID: 21665482
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular docking study of novel allyl-retrochalcones as a new class of protein tyrosine phosphatase 1B inhibitors.
Zhao Y; Cao Y; Chen H; Zhuang F; Wu C; Yoon G; Zhu W; Su Y; Zheng S; Liu Z; Cheon SH
Bioorg Med Chem; 2019 Mar; 27(6):963-977. PubMed ID: 30737132
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.
Liu Z; Lee W; Kim SN; Yoon G; Cheon SH
Bioorg Med Chem Lett; 2011 Jun; 21(12):3755-8. PubMed ID: 21555221
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
[TBL] [Abstract][Full Text] [Related]
11. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
13. Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors.
Kolb S; Mondésert O; Goddard ML; Jullien D; Villoutreix BO; Ducommun B; Garbay C; Braud E
ChemMedChem; 2009 Apr; 4(4):633-48. PubMed ID: 19212959
[TBL] [Abstract][Full Text] [Related]
14. Effective Pharmacophore for CDC25 Phosphatases Enzyme Inhibitors: Newly Synthesized Bromothiazolopyrimidine Derivatives.
El-Shahat M; Salama MAM; El-Farargy AF; Ali MM; Ahmed DM
Mini Rev Med Chem; 2021; 21(1):118-131. PubMed ID: 32560601
[TBL] [Abstract][Full Text] [Related]
15. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
Rakse M; Karthikeyan C; Deora GS; Moorthy NS; Rathore V; Rawat AK; Srivastava AK; Trivedi P
Eur J Med Chem; 2013; 70():469-76. PubMed ID: 24185377
[TBL] [Abstract][Full Text] [Related]
18. [Design, synthesis and evaluation of malonic acid-based PTP1B inhibitors].
Du X; Zhang SE; Liu JZ; Nie FL; Ye F; Tian JY; Xiao ZY
Yao Xue Xue Bao; 2012 Mar; 47(3):367-73. PubMed ID: 22645761
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused libraries.
Tao Y; Hao X; Jing L; Sun L; Cherukupalli S; Liu S; Wu G; Xu S; Zhang X; Shi X; Song Y; Liu X; Zhan P
Bioorg Chem; 2021 Oct; 115():105254. PubMed ID: 34426152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
